EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Racial and Ethnic Disparities in Pharmacologic and Non‐Pharmacologic Pain Management Among Older Cancer Survivors

Oindrila Bhattacharyya iD, Mohamed I Elsaid iD, Brittany E Punches, Andy Ni, Ashley S Felix, Macarius M Donneyong

Cancer Medicine · 2026

DOI: 10.1002/cam4.71536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Oindrila Bhattacharyya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Cancer Pain, Cancer Survivors, Healthcare Disparities, Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries, NCI NIH HHS, CCTS Pilot Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pain is common among cancer survivors and often managed with medication; however, racial‐ethnic disparities persist in pain treatment. Given inadequate data on pharmacologic and non‐pharmacologic pain management among minoritized cancer survivors, we investigated these patterns using the SEER‐Medicare claims linked database.

Methods

An incident cancer diagnosis cohort (≥ 66 years) was created from 2007 to 2016. The primary outcome was incidence of pain treatment (pharmacologic and non‐pharmacologic) within 90 days post‐diagnosis. Racial disparities were measured as adjusted incidence ratios for treatment using Poisson regression and adjusted differences in supply days and doses using linear regression, comparing non‐Hispanic Black (nHB), Hispanic‐Latino (LatinX), Asian/Pacific Islander (API), and Others to non‐Hispanic White (nHW). Models were adjusted for demographic and clinical variables.

Results

Among 300,048 survivors—nHW (72.9%), nHB (9.6%), LatinX (8.8%), API (7.3%), Others (1.4%)—nHB (aIR = 0.96, 95% CI, 0.95–0.98), API (aIR = 0.96, 95% CI, 0.95–0.98) and Others (aIR = 0.91, 95% CI, 0.87–0.94) used less pain treatment overall than nHW. Opioids (80% of treatments) were less frequently utilized by males of the Other race‐ethnicity group (aIR = 0.75, 95% CI, 0.70–0.81), compared to nHW males. For non‐opioids, nHB males (aIR: 0.84, 95% CI, 0.79–0.88) were less likely to use these therapies as compared to nHW males. Non‐pharmacological treatments were less utilized by nHB (aIR = 0.65, 95% CI, 0.62–0.69) and LatinX survivors (aIR = 0.69, 95% CI, 0.65–0.73), as compared to nHWs. Minority survivors received lower opioid doses for longer durations, but higher non‐opioid doses for shorter durations.

Conclusion

There are considerable racial‐ethnic disparities in the utilization of pharmacologic and non‐pharmacologic pain treatments among cancer survivors. Future research should explore the drivers of these inequities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer PainCancer SurvivorsHealthcare DisparitiesNeoplasmsPain ManagementAgedAged, 80 and overFemaleHumansMaleAnalgesics, OpioidMedicareSEER ProgramUnited StatesHispanic or LatinoRacial Groups

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Department of Biomedical Informatics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Department of Internal Medicine, Division of Medical Oncology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • College of Nursing, The Ohio State University, Columbus, Ohio, USA.
  • Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.

ORCID-Profile: Oindrila Bhattacharyya, Mohamed I Elsaid

Förderung

  • Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries
  • NCI NIH HHS
  • CCTS Pilot Grant
  • NCATS NIH HHS
  • California Department of Public Health pursuant to California Health and Safety Code Section
  • Public Health Institute
  • University of Southern California

Zitieren

APA

Bhattacharyya, O., Elsaid, M. I., Punches, B. E., Ni, A., Felix, A. S., & Donneyong, M. M. (2026). Racial and Ethnic Disparities in Pharmacologic and Non‐Pharmacologic Pain Management Among Older Cancer Survivors. Cancer Medicine. https://doi.org/10.1002/cam4.71536

Vancouver

Bhattacharyya O, Elsaid MI, Punches BE, Ni A, Felix AS, Donneyong MM. Racial and Ethnic Disparities in Pharmacologic and Non‐Pharmacologic Pain Management Among Older Cancer Survivors. Cancer Medicine. 2026. doi:10.1002/cam4.71536

BibTeX
@article{Bhattacharyya2026,
  author = {Bhattacharyya, Oindrila and Elsaid, Mohamed I and Punches, Brittany E and Ni, Andy and Felix, Ashley S and Donneyong, Macarius M},
  title = {Racial and Ethnic Disparities in Pharmacologic and Non‐Pharmacologic Pain Management Among Older Cancer Survivors},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71536}
}
Kostenlos starten →